Respana Therapeutics receives support from Pennsylvania’s COVID-19 Vaccines, Treatments and Therapies (CV-VTT) Program Press Release – September 1, 2020 “Funding Will Be Used to Advance the Company’s Novel Monoclonal Antibody.” For Immediate Release September 1, 2020 Read More